Navigation Links
Tolerance to inhalants may be caused by changes in gene expression
Date:10/17/2007

a relaxed state, gene transcription occurs more frequently.

The researchers predict that increased expression of the slo channels, through epigenetic modifications to the histones, helped neurons recover from sedation and resist the effects of the drug, increasing tolerance.

"While the fruit fly seems very different from us, the cells of its nervous system are remarkably similar to ours and can be used to understand how drugs change our brains," Atkinson said.


'/>"/>

Contact: Nigel Atkinson
nigela@mail.utexas.edu
512-232-3404
University of Texas at Austin
Source:Eurekalert

Page: 1 2

Related biology news :

1. Mouse with designer liver has enhanced glucose tolerance, insulin response
2. Lactose intolerance linked to ancestral environment
3. UNC launches study of liver injury caused by drugs
4. Oxygen increase caused mammals to triumph, researchers say
5. Blocking the nerve receptor EP1 in mouse models reduces brain damage caused by stroke
6. Stem cell mobilization therapy appears to be ineffective in repairing damage caused by heart attack
7. Whiplash injuries ?are they caused by startle reflexes?
8. Man may have caused pre-historic extinctions
9. Cocaine high caused by interference in neuronal receiving stations
10. Scientists discover new virus caused deaths of transplant recipients from single donor
11. New study may show how to forestall a fatal, virus-caused immune-system meltdown
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... a standard laboratory model organism, but there are ... analyze blood and blood-forming tissues in this species. ... easy-to-use laboratory resources from Cold Spring Harbor Laboratory ... features step-by-step protocols for the preparation, enumeration, ... and other hematopoietic tissues in the mouse. ...
(Date:12/14/2009)... promoted as a clean-burning, renewable fuel that could help ... problems caused by ozone, compared with gasoline, especially in ... researchers. , Ozone production from both gasoline and ... 85 percent ethanol, is greater in warm sunny weather ... winter, because heat and sunlight contribute to ozone formation. ...
(Date:12/14/2009)... (INTA-CSIC) has shown that hydrogen cyanide, urea and other ... basic biological molecules can be obtained from the salt ... published in the journal Chemistry & Biodiversity , ... Earth. , "We have shown that when Prussian blue ... a substance that could have played a fundamental role ...
Breaking Biology News(10 mins):New source of classical techniques for blood-based studies in the laboratory mouse 2Ethanol-powered vehicles generate more ozone than gas-powered ones 2Ethanol-powered vehicles generate more ozone than gas-powered ones 3Prussian blue linked to the origin of life 2University Medical Center Mainz Completes Installation of Masimo Noninvasive and Continuous Hemoglobin Throughout Their Operating Rooms Intensive Car 58032 1University Medical Center Mainz Completes Installation of Masimo Noninvasive and Continuous Hemoglobin Throughout Their Operating Rooms Intensive Car 58032 2University Medical Center Mainz Completes Installation of Masimo Noninvasive and Continuous Hemoglobin Throughout Their Operating Rooms Intensive Car 58032 3University Medical Center Mainz Completes Installation of Masimo Noninvasive and Continuous Hemoglobin Throughout Their Operating Rooms Intensive Car 58032 4University Medical Center Mainz Completes Installation of Masimo Noninvasive and Continuous Hemoglobin Throughout Their Operating Rooms Intensive Car 58032 5Media small businesses invited to ACS webinar on green chemistry project financing 58027 1K State geographer working to clarify what sustainability really means to rural decision makers 10035 1K State geographer working to clarify what sustainability really means to rural decision makers 10035 2
... October 9, 2007 MIT Holding, Inc. (OTCBB: MITD), ... successfully tested prototype designs of the patent pending PROVECTOR. ... development of pathogens and parasites found in mosquitoes that ... West Nile virus. The PROVECTOR will initially be made ...
... rats with portal hypertension, ultraClow-dose aspirin has shown a ... Further, this effect is mediated by Cyclooxygenase 2 inhibition. ... team led by Professor C. Doutremepuich, is described in ... 14 issue of the World Journal of Gastroenterology. , ...
... Professor Sir Martin Evans, Professor of Mammalian Genetics at ... 2007 Nobel Prize for Medicine. , The Nobel Assembly ... Professor Sir Martin was one of three winners for ... and DNA recombination in mammals. , Professor Sir Martin ...
Other Biology News:MIT Holding, Georgia Southern University, and MEVLABS successfully test the PROVECTOR 2Ultra-low-dose aspirin might decrease bleeding severity in portal hypertension 2Professor Sir Martin Evans wins Nobel Prize for Medicine 2
(Date:12/15/2009)... Dec. 15 Reportlinker.com announces that ... in its catalogue: ,, The ... Forecasts to 2015, Pipeline Analysis and Reimbursement ... ,, Summary ,, ... "The Future of Orphan Diseases Therapeutics - ...
(Date:12/15/2009)... Dec. 15 The Mosaic Company (NYSE: ... year 2010 earnings results and financial tables on Tuesday, ... the New York Stock Exchange. Results will be ... The Company will host a conference call with presentation ... results. The call will begin at 11:00 a.m. ...
(Date:12/15/2009)... Dec. 15 Thomson ... ® has become the first drug pipeline database ... outcome information. This highly anticipated new content is ... month. ,, Thomson Pharma ... registries, publications, press releases, conferences, and other sources ...
(Date:12/14/2009)... 14 Vermillion, Inc. (Pink Sheets: ... William C. Wallen, Ph.D. Chief Scientific Officer, ... IDEXX Laboratories, will be joining its board ... plan. ,, "Bill brings more than ... diagnostics and biotechnology," said Gail Page, Vermillion ...
Breaking Biology Technology:Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 2Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 3Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 4Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 5Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 6Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 7Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 8Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 9Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 10Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 11Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 12Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 13Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 14Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 15Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 16Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 17Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 18Mosaic Announces Second Quarter Fiscal Year 2010 Earnings Release and Conference Call 2Thomson Reuters is First to Offer Fully Integrated Pipeline and Clinical Trials 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 3Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 4
... Ala., Oct. 31 BioCryst,Pharmaceuticals, Inc. (Nasdaq: ... ended September 30, 2008., Third Quarter 2008 ... September 30, 2008, the Company reported,collaborative and other ... $20.5 million for the three months ended September ...
... Full-Year 2008, PLYMOUTH, Minn., Oct. 31 ev3 ... financial,results for its fiscal third quarter of 2008 and ... were $107.0 million in the third quarter of 2008,representing ... prior year,primarily due to the acquisition of FoxHollow. Third ...
... Va. -- Wind, water, and waves erode billions of ... result, many rivers are plagued with excessive amounts of ... such eroded sediment is the largest nonpoint source pollution ... soil erosion may seem obvious wind, water and wave ...
Other Biology Technology:BioCryst Reports Third Quarter 2008 Financial Results and Provides Corporate Update 2BioCryst Reports Third Quarter 2008 Financial Results and Provides Corporate Update 3BioCryst Reports Third Quarter 2008 Financial Results and Provides Corporate Update 4BioCryst Reports Third Quarter 2008 Financial Results and Provides Corporate Update 5BioCryst Reports Third Quarter 2008 Financial Results and Provides Corporate Update 6BioCryst Reports Third Quarter 2008 Financial Results and Provides Corporate Update 7BioCryst Reports Third Quarter 2008 Financial Results and Provides Corporate Update 8BioCryst Reports Third Quarter 2008 Financial Results and Provides Corporate Update 9ev3 Inc. Reports Third Quarter 2008 Financial Results 2ev3 Inc. Reports Third Quarter 2008 Financial Results 3ev3 Inc. Reports Third Quarter 2008 Financial Results 4ev3 Inc. Reports Third Quarter 2008 Financial Results 5ev3 Inc. Reports Third Quarter 2008 Financial Results 6ev3 Inc. Reports Third Quarter 2008 Financial Results 7ev3 Inc. Reports Third Quarter 2008 Financial Results 8ev3 Inc. Reports Third Quarter 2008 Financial Results 9ev3 Inc. Reports Third Quarter 2008 Financial Results 10ev3 Inc. Reports Third Quarter 2008 Financial Results 11ev3 Inc. Reports Third Quarter 2008 Financial Results 12ev3 Inc. Reports Third Quarter 2008 Financial Results 13ev3 Inc. Reports Third Quarter 2008 Financial Results 14ev3 Inc. Reports Third Quarter 2008 Financial Results 15ev3 Inc. Reports Third Quarter 2008 Financial Results 16ev3 Inc. Reports Third Quarter 2008 Financial Results 17ev3 Inc. Reports Third Quarter 2008 Financial Results 18ev3 Inc. Reports Third Quarter 2008 Financial Results 19ev3 Inc. Reports Third Quarter 2008 Financial Results 20Virginia Tech engineers identify conditions that initiate erosion 2Virginia Tech engineers identify conditions that initiate erosion 3
... FLISP Assay with FAM-Labeled Substrate (green ... Accurately measure serine protease activation • ... B-Bridge's FLISP Kits utilize cell-permeable, fluorescently ... to measure chymotrypsin-like activity in whole ...
Request Info...
... provides the firm pressure necessary to ... tubes or plates. The multifunctional tool ... firmly holds thin-wall 0.5 ml tubes ... or closing. A side slot allows ...
... The Gene Pulser Xcell microbial system, ... is used for electroporation of bacterial ... the main unit, PC module for ... 10 sterile cuvettes (5 each of ...
Biology Products: